Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer

PURPOSE: This study aimed to evaluate the survival benefit of different adjuvant chemotherapy regimens in patients with T1-2N0 triple-negative breast cancer. METHODS: Of 67,321 patients who were registered in the Korean Breast Cancer Society nationwide database between January 1999 and December 2008...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun-Ah, Seong, Min-Ki, Kim, Eun-kyu, Kang, Eunyoung, Park, Seho, Hur, Min Hee, Song, Byung Joo, Noh, Woo Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600692/
https://www.ncbi.nlm.nih.gov/pubmed/26472978
http://dx.doi.org/10.4048/jbc.2015.18.3.271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600692/
https://www.ncbi.nlm.nih.gov/pubmed/26472978
http://dx.doi.org/10.4048/jbc.2015.18.3.271

Ejemplares similares